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Renovascular hypertension can result from renal artery lesions involving the main renal artery, or its
branches. It is generally felt that theelevation ofblood pressure results from excessive systemic vasoconstric-
tion secondary to enhanced renin secretion by one or part of one kidney. Renin secretion is enhanced
because of constriction of the renal artery and resultant intrarenal ischemia. Clinically patients cannot be
distinguished from those with essential hypertension and diagnosis must be made with arteriography
although urography and isotope renography may suggest the diagnosis. Surgical cure can be predicted if
differential renal vein renin ratios lateralize but a non-lateralizing study does not necessarily mean that
surgery will fail. In properly selected patients, surgical results are excellent.
Renovascular hypertension is most commonly recognized in patients with stenosis
of a main renal artery, but stenosis or obstruction of renal artery branches, extrinsic
masses which compress the kidney, and renal parenchymal lesions that result in
ischemia can also cause renovascular hypertension. One or both kidneys may be
involved. Since renal artery stenosis may be present in patients without hypertension
and since repair of a stenotic renal artery does not always cure hypertension, surgical
cure is the only definite criterion for establishing a causal relationship between an
anatomic renal abnormality and hypertension [1].
The first surgical cure of hypertension was reported in 1937 [2], shortly after
Goldblatt and co-workers demonstrated that dogs could be made hypertensive by
constricting one renal artery and removing the contralateral kidney [3]. The concept
of surgical therapy for hypertension was appealing, since effective antihypertensive
drug therapy was not available. However, a summary in 1956 of results of approxi-
mately 2,000 nephrectomy operations in hypertensive patients revealed that only 20
percent were normotensive one year after operation [4]. Since then, much investiga-
tive effort has been directed at improving diagnostic procedures to distinguish
patients with surgically curable hypertension from those in whom surgery would be
futile. During these two decades safe, inexpensive, and effective drug regimens have
developed as well, offering an alternative to surgery and making it more important to
carefully select patients for operation.
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Goldblatt first suggested that the direct cause of some forms of hypertension was
hypersecretion of a pressor substance released by the kidney in response to ischemia.
He implicated renin, an enzyme produced, stored, and secreted by granular cells
located in the walls of the afferent arterioles and adjacent to the glomeruli (the
juxtaglomerular apparatus). Renin cleaves angiotensinI, a ten amino acid peptide,
from renin substrate. Angiotensin I is then metabolized in the lungs and elsewhere by
converting enzyme to angiotensinII, an octapeptide which raises blood pressure by
two distinct mechanisms: (1) angiotensin II is a potent vasoconstrictor; (2) angioten-
sinII, both directly and after further metabolism to angiotensinIII, stimulates the
secretion of aldosterone by the adrenal cortex. Aldosterone, a potent mineralocorti-
coid, increases sodium reabsorption from the distal tubules resulting in increased
blood volume and blood pressure.
The renin-angiotensin system is only one of several mechanisms that regulate
blood pressure. It appears to be a critical factor in maintaining blood pressure in the
upright position and during hypovolemia [5]. The importance of the renin-
angiotensin system in the normovolemic individual is less clear. The precise physio-
logic stimulus for renin release is unknown; renal perfusion pressure, sodium
transport, and the sympathetic nervous system all play some role. Whatever the
stimulus, inappropriate renin hypersecretion is associated with some forms of
hypertension.
Laragh and co-workers have suggested that hypertension results from abnormali-
ties in either blood volume regulation or the degree of systemic vasoconstriction [6].
Hypertension results from hypervolemia in primary aldosteronism and in hyperten-
sion related to decreased renal mass [7]. In these conditions the renin-angiotensin
system plays a minor role. Vasoconstriction is probably the primary mechanism in
renovascular hypertension. Renin hypersecretion results in excessive systemic levels
of angiotensin II leading to generalized vasoconstriction and hypertension. Natriure-
sis and diuresis are induced in the unaffected kidney, reducing plasma volume and
further contributing to systemic vasoconstriction.
The discovery of agents which can interfere with the renin-angiotensin system has
lent strong support to the volume-vasoconstriction hypothesis. Saralasin, a competi-
tive inhibitor of angiotensin II, blocks the action of angiotensin II at vascular smooth
muscle receptors [8]. In animals, hypertension can be produced with either of two
surgical models. In the one-kidney model, the artery supplying one kidney is
constricted, and the other kidney is removed. In the two-kidney model, which more
closely resembles renovascular hypertension in humans, one renal artery is con-
stricted and the opposite kidney and renal artery are left undisturbed. Saralasin
lowers blood pressure in the two-kidney model, suggesting that hypertension in this
model is due to vasoconstriction [9]. Saralasin is ineffective in the one-kidney model,
suggesting a volume-dependent form of hypertension. Under conditions of salt
depletion, blood pressure is reduced by Saralasin in the one-kidney model, but blood
pressure in the two-kidney model fails to fall with Saralasin infusion if normal
plasma volume is maintained [10].
These studies indicate that both blood volume and vasoconstriction are important
variables, and both must be considered in attempting to clarify the nature of any
individual case of hypertension. This interrelationship between plasma volume and
renin levels makes careful control of plasma volume important during diagnostic
evaluation for renal vascular hypertension. Failure to consider the role of plasma
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volume changes may have led to some of the incorrect predictions of surgical results
in some series.
TYPES OF RENOVASCULAR-RENIN DEPENDENT HYPERTENSION
Atherosclerosis is the most common cause of hemodynamically significant renal
artery stenosis. Renovascular hypertension due to atherosclerosis occurs most
commonly in men and seldom in patients under 40 years of age, although rare cases
have been reported in children. The main renal artery is usually narrowed at or
adjacent to its origin. The stenosis is usually eccentric and the luminal surface
irregular. Bilateral renal artery stenoses are common.
Angiographic demonstration of renal artery stenosis characteristic ofatherosclero-
sis is not sufficient to diagnose renovascular hypertension. In a series ofpostmortem
arteriograms, moderate to severe atherosclerotic renal artery stenosis was found in as
many as 49 percent of individuals who had not been hypertensive. The use of renal
vein renin assays to demonstrate renin-dependent hypertension and verify the
significance of the arteriographic lesion will be discussed below.
In older patients, renal scarring and atrophy is common. If renal artery branch
stenosis, localized scars, or areas of infarction are identified, renal venous samples
should be drawn selectively from the involved segmental veins as well as from the
main renal veins in order to determine whether renin hypersecretion results from an
intrarenal lesion or from stenosis of the main renal artery.
Fibromuscular arteriopathy is the most common cause of renovascular hyperten-
sion in patients under 40, but may occur at any age. The disease occurs in women
four to five times more frequently than in men in most large series. The right renal
artery is involved more commonly than the left, but the lesion isfrequently bilateral.
Progression of the degree of stenosis and extension of the length of the lesion
commonly occurs in patients treated both surgically and non-surgically. Fibromuscu-
lar disease may become manifest in the contralateral kidney up to several years after
its presentation in the ipsilateral kidney.
The etiology is unknown. The predominance of right sided lesions has led some
authors to postulate that the lesions result from renal ptosis or hypermobility [11].
Supporting evidence for this hypothesis is scarce. Pregnancy has been suggested as a
contributory pathogenic factor, but the substantial number of men and nulliparous
women with fibromuscular arteriopathy cannot be explained by this hypothesis [12].
Histologically identical lesions have been found in numerous arteries other than the
renal arteries, which suggests that this may be a generalized systemic arteriopathy
[13]. Other suggested etiologies include trauma, embryologic variation, proliferative
endarteritis resulting from vascular hyperactivity, and mural ischemia resultingfrom
compromise of vasa vasorum [12,14].
Numerous histologic subclassifications have been proposed, based on the layer of
the arterial wall which is most severely affected, and also based on whether the lesion
consists of fibrous tissue or hyperplasia of smooth muscle [12,14,15]. Characteristic
arteriographic appearances and differences in the natural history of the disease have
been described with specific histologic variants, but considerable controversy still
exists. Most investigators agree that at least three variants of this disease can be
separated: intimal fibroplasia, fibromuscular hyperplasia, and medial fibroplasia.
Intimal fibroplasia consists ofcircumferential accumulation ofcollagen withinthe
internal elastic lamina. This variant has been found in five to ten percent ofpatients
with fibromuscular arteriopathy [12,16]. It is most commonly seen in children and
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Intimal fibroplasia is frequently progressive, and dissection and obstruction of the
renal artery are common [16]. By arteriography, this lesion characteristically
produces long tubular narrowing of the midportion of the renal artery.
True fibromuscular hyperplasia is the least common variant of fibromuscular
arteriopathy, comprising only one to five percent of patients in this group [15,16]
This variant apparently occurs with similar frequency in men and women. It, too, is
frequently progressive and is associated with a high incidence of intramural dissec-
tion [15]. The arteriographic appearance of fibromuscular hyperplasia is often
indistinguishable from that of intimal fibroplasia. Smooth tubular narrowing is
present in the mid and distal thirds ofthe renal artery, frequently extending into renal
artery branches.
Medial fibroplasia consists of circumferential fibrous rings that replace the
muscular media of the vessel, alternating with short segments in which the media is
thinned or absent and the lumen is dilated. This is the most common variant
occurring in 75 to 85 percent of the patients with fibromuscular arteriopathy. It is
found in all age groups and predominantly affects women [12,16]. It is also the most
easily recognizable variant, as it has a virtually specific angiographic appearance. A
long segment of the main renal artery, beginning in the middle third, contains
segmental constrictions alternating with aneurysmal dilatations. The dilatations
appear to be true aneurysms, since some or all ofthem are larger in diameter than the
uninvolved portions of the renal artery. This appearance can be differentiated from
that of another variant, frequently called fibroplasia, which also has a beaded
angiographic appearance. In subadventitial fibroplasia, the dilatations are smaller in
caliber than the uninvolved portions of the renal artery.
Recognition of medial fibroplasia has clinical importance since this variant seems
to progress more slowly than the others. Stewart and co-workers have reported 41
patients with this angiographic appearance who were treated conservatively [16]. The
lesion progressed in only two patients, and no progression was observed in any
patient over 40 years of age. Other series have documented greater frequency of
progression and progression in some patients older than 40, but even in these series
the lesion progressed in fewer than 30 percent of patients [15]. The incidence of
dissection and other complications also appears lower in this variety than in other
forms of fibromuscular arteriopathy.
Hypertension occurs in approximately 10 percent of patients with neurofibromato-
sis. In patients under 18 years old, renal artery stenosis is the usual cause, although
many of these patients have abdominal aortic coarctation as well. Pheochromocy-
toma is also associated with neurofibromatosis and is the most common cause of
hypertension in patients with neurofibromatosis whose hypertension begins after the
age of eighteen [17].
Renal artery stenosis associated with neurofibromatosis is most commonly located
at the origin of the main renal artery. Post-stenotic dilatation is often present [18].
Renal artery stenoses are occasionally bilateral, and in one-fifth of reported cases the
aorta adjacent to the renal arteries is also narrowed [19].
In most instance, renal artery stenosis results from intimal fibrous or cellular
proliferation, but in some patients neurofibromas within the arterial adventitia have
caused stenosis. Although the number ofcases reported to date is relatively small and
the time of followup is relatively short, surgical revascularization has often been
successful [18,20]. Progression of stenosis has seldom been documented, although in
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one reported case renal artery stenosis recurred following surgical resection of
bilateral stenoses and reimplantation of the renal arteries into the aorta [20].
Renal artery branchstenosis may result from extension offibromusculardisease of
the main renal artery, but occasionally is found in the absence of main renal artery
disease. Branch stenosis or obstruction may also result from atherosclerosis, emboli-
zation of a mural thrombus from the heart, arteritis, trauma, or vasospastic diseases
such as ergotism.
Several renal parenchymal diseases have been associated with renin-dependent
hypertension. Considerable controversy exists about the etiology an-d classification of
these diseases, such as chronic pyelonephritis and segmental hypoplasia, and many
pathologists agree that the classical histologic findings previously considered specific
for chronic pyelonephritis secondary to infection may also be the end result of other
pathological processes [21]. Considerable evidence suggests that many patients who
in the past have been treated with antibiotics in the beliefthat thedisease was caused
by repeated infection have instead been sufferingfrom chronic vesico-ureteral reflux.
Their deteriorating renal function may have been a result of chronically elevated
caliceal pressure rather than infection or even inflammation [22].
Radiologic criteria for the diagnosis of pyelonephritis have consisted of focal or
generalized scarring. In view of the clinical and pathological uncertainty of this
diagnosis it must be recognized that these urographic findings are non-specific, at
least after the age of 25. Scarring following vesico-ureteral reflux, renal infarction,
trauma, or other renal insults can produce the same urographic abnormalities [23].
Renin-dependent hypertension has been documented in occasional patients with
urographic, clinical, and microscopic findings formerly considered to represent
pyelonephritis [24]. Thickening ofthe walls ofblood vessels in areas ofinvolvement is
described as part of the characteristic microscopic picture. Renin-dependent hyper-
tension has been demonstrated in patients with renal parenchymal scarring or
atrophy that has resulted from trauma, renal tuberculosis, infarction, vesico-ureteral
reflux, and hydronephrosis.
Central segmental renal scarring was described by Ask-Upmark and has been
considered to result from congenital hypoplasia [25]. This hypothesis is now in
doubt, however, since several cases have been described in which histologically
identical lesions have appeared in previously normal kidneys following chronic
vesico-ureteral reflux [26]. Like "chronic pyelonephritis," "segmental renal hypopla-
sia" is not a specific diagnosis but a syndrome whose mechanism cannot be inferred
from its appearance, unless reflux is demonstrated.
Hypertension is frequently present at the end-stage of many renal parenchymal
diseases, and occasionally occurs in patients with scarred kidneys but well-preserved
renal function. Goddard and co-workers [27] have called attention to the frequent
presence of hypertension in children with Ask-Upmark kidneys, and Meares and
Gross have reported adult onset of hypertension associated with this syndrome[28].
Elevated renal vein renin levels and a favorable response to nephrectomy in many of
these patients suggests that the mechanism ofhypertension, at least in some instances
of renal scarring or atrophy, is similar to that in renal artery stenosis. These authors
and others have postulated that ischemic zones develop between fibrous tissue and
healthy parenchyma and give rise to renin hypersecretion. Hyperplasia of the
juxtaglomerular apparatus has been demonstrated microscopically in renal paren-
chyma adjacent to hypoplastic or scarred segments [27].
Arteriolar nephrosclerosis may result from severe atherosclerosis or from long-
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sion may be irreversible even if a localized ischemic zone of parenchyma or an arterial
stenosis can be demonstrated and renin hypersecretion verified by renin assay [29].
Arteriographic signs include rapid tapering of intrarenal arteries, diminution in the
number of arcuate arteries that are opacified, tortuosity of peripheral arteries, and
diminished cortical thickness [30]. Renal artery blood flow rate is reduced from
normal. Reduced renal flow rate can be recognized by comparing flow in the renal
arteries to that in other abdominal arteries on the aortogram.
Renin-dependent hypertension has been only rarely associated with expansile renal
masses, and in all reported cases the mass has been a renal cyst [31]. The mechanism
appears to be direct compression of intrarenal arteries by the mass, leading to
parenchymal ischemia and renin hypersecretion, since renin-dependent hypertension
has been reported only in cases with severe distortion of renal parenchyma. Benign
cysts are more likely to produce significant parenchymal compression than are
abscesses or tumors, since cysts do not infiltrate or destroy renal tissue.
In the presence of an expansile mass in a hypertensive patient, selective magnifica-
tion arteriograms should be carefully reviewed to exclude other potential causes of
renal hypersecretion. Since the source ofrenin hypersecretion is intrarenal, and renin
secretion from distorted segments of the same kidney may be suppressed, blood
samples for renin assay should be drawn from segmental veins within the kidneys.
Reversal of hypertension may result after removal of the mass, but not always [32].
Renin hypersecretion may be irreversible if parenchymal compression has been
sufficiently long-standing.
Renin-dependent hypertension has also been associated with subcapsular and
extracapsular masses that produce compression of renal parenchyma. In most
reported cases the mass was a post-traumatic hematoma. The absence of intrinsic
arterial abnormalities, elevation of renin in the venous blood draining the affected
kidney compared to the opposite kidney, and reversal of hypertension following
surgery verify this mechanism [33]. A similar lesion was produced in several animal
species and reported as early as 1939 by Page [34]. He wrapped one kidney in
cellophane and subsequently noted a thick perirenal scar that altered intrarenal
dynamics and induced hypertension which could be reversed by nephrectomy.
To date, all but one of the reported renin-secreting tumors have been benign
tumors of renal origin with similar histologic characteristics [35]. The exception was
a Wilm's tumor in which autonomous renin secretion was demonstrated [36].
Although the benign renin-secreting tumors contain multiple cellular elements and
can therefore be considered hamartomas, the predominant cell types have character-
istics that suggest they are derived from thejuxtaglomerular apparatus ofthe kidney.
They contain granules whose ultrastructural characteristics are similar to those in the
juxtaglomerular apparatus [37]. Other cells appear to be derived from those of renal
tubules.
These rare tumors have been reported only in patients below the age of thirty-five.
They present with hypertension which is usually severe and uncontrollable pharma-
cologically. Characteristic laboratory abnormalities include hypokalemia and hyper-
aldosteronism. Since in at least one of the reported cases aldosterone secretion could
not be suppressed by DOCA, the distinction between renin-secreting tumors and
primary aldosteronism may be difficult [35]. Renin-secreting tumors are small in size
and may be below the limits of resolution of intravenous urography, radionuclide
examination, and even aortography, further adding to the diagnostic difficulty.
640 BLACK ET AL.RENOVASCULAR HYPERTENSION
However, in all previously reported cases plasma renin activity has been elevated,
whereas in primary aldosteronism plasma renin activity is characteristically low.
The most sensitive radiographic means of demonstrating small renal masses is
selective renal arteriography using magnification techniques. Once the diagnosis is
suspected on the basis of elevated plasma renin activity and renal arteriography, it
can be confirmed by renin assay of renal vein blood samples from veins draining the
tumor. Complete or partial nepbrectomy is curative.
Renal ischemia occasionally results from compression of the main renal artery by
extrinsic lesions. Non-malignant structures that have compressed renal arteries to
produce surgically reversible hypertension include congenital fibrous bands and
hypertrophied adrenal tissue [38]. Tumors such as lymphosarcoma, renal adeno-
carcinoma located in the hilum, pheochromocytoma, and metastases from the
sigmoid colon and lung have been implicated in the pathogenesis of hypertension
[39,40].
True renal artery aneurysms are usually associated with atherosclerosis or fibro-
muscular disease. Aneurysms are occasionally found in the absence of underlying
arterial disease [41,42] These may result from congenital or degenerative factors.
False aneurysms result from inflammation or trauma. The majority of renal artery
aneurysms are asymptomatic and do not rupture or cause hypertension. The
mechanism of hypertension associated with renal artery aneurysm has aroused
considerable speculation: embolization of mural thrombi from within the aneurysm
to segmental renal arteries, compression of renal artery branches by a high-pressure
pulsatile aneurysm, or undetected stenosis proximal or distal to an aneurysm have
been proposed.
Renal arteriovenous fistula most commonly results from penetrating tra-uma,
rupture of a renal artery aneurysm, surgery, or renal biopsy [38]. Arteriovenous
fistulae may escape detection at surgical exploration or on pathologic examination.
Auscultation of a bruit or abrupt onset ofhypertension following an injury or biopsy
should raise suspicion of a renal arteriovenous fistula. Arteriography is required for
definitive diagnosis.
Because of the abrupt pressure drop across an arteriovenous fistula, most of the
renal artery flow is diverted through the fistula, and the renal parenchyma distal to
the fistula becomes ischemic, resulting in hypertension and renin hypersecretion. If
an arteriovenous fistula is identified soon after it develops, the arterial supply may
arise primarily from the renal artery, and local resection or partial nephrectomy may
be possible. If there is a lag between development of the fistula and surgery, arterial
collaterals may enlarge and contribute to the fistula. The presence of collateral
circulation considerably increases the technical difficulty of surgical resection,
increases the morbidity of resection, and often mandates complete nephrectomy.
Angiographic occlusion of the fistula with a balloon catheter is a therapeutic
approach that may be useful as an alternative to surgery for intrarenal arteriovenous
fistulae.
CLINICAL PRESENTATION
The National Cooperative Study on Renovascular Hypertension in 1972 described
the clinical characteristics of 2,442 hypertensive patients, 880 of whom had renovas-
cular hypertension [43,44]. Compared to patients with essential hypertension, those
with renovascular hypertension: tended to have hypertension for a shorter period of
time; more often had no family history of hypertension; had more severe fundscopic
641abnormalities; had bruits in the mid-abdomen six to nine times more frequently;
more often had hypokalemia, alkalemia, and azotemia.
However, this study reported no greater frequency of accelerated hypertension or
of pharmacologically uncontrollable hypertension in patients with renovascular
disease, and no difference was found in the frequency of excessive tension or anxiety
between hypertensive groups, contrary to prior reports. Postural hypotension was
more common with renovascular hypertension than with essential hypertension but
not significantly so, and patients with renovascular hypertension due to atherosclero-
sis had a higher frequency of peripheral vascular disease, aortic aneurysm, and
proteinuria. While renovascular hypertension was more common inpatients under20
and over 50, significant numbers ofpatients with essential hypertension were younger
than 20 or older than 50.
Based on the Cooperative Study data, Maxwell has suggested that patients with an
abdominal or flank bruit who also have an abnormal urogram or renogram are very
likely to have renovascular hypertension, and conversely patients with no bruits and
normal urograms and renograms are virtually certain of having essential hyperten-
sion. In the patients studied in the National Cooperative Study only 1.6 percent of
those without a bruit and with a normal urogram and renogram had renovascular
hypertension [45]. This thesis may only apply to patients whose hypertension is
associated with main renal artery stenosis. Many other diseases of unknown
frequency have been associated with surgically curable hypertension, so that clinical
application of these findings may be premature.
DIAGNOSTIC EVALUATION
Selection of Patientsfor Evaluation
Renovascular hypertension results from a large variety of conditions. While
atherosclerosis and fibromuscular dysplasia are the most common, renin-dependent
hypertension may result from tumors, trauma, fibrosis, infections, and arterial
aneurysms and arteriovenous malformations. (See above). These patients may be
indistinguishable from those with essential hypertension and so the clinician must be
familiar with the risks, benefits, and relative usefulness of the many diagnostic
procedures available and know which patients should be extensively studied and
which should merely be treated once a simple evaluation is completed.
Diagnostic evaluation for renovascular hypertension can be arbitrarily considered
to consist of three steps: (1) demonstration of the abnormality, (2) functional
evaluation to prove that the abnormality is responsible for the hypertension, and
(3) cure or significant improvement after successful surgery. Definitive demonstra-
tion of an anatomic abnormality that may be responsible for hypertension requires
arteriography. The functional significance of an abnormality demonstrated by
arteriography should be verified by renin assay ofblood samples obtained selectively
from the renal vein, by pharmacoangiography, or both before surgery is considered.
Since these procedures are expensive, uncomfortable, and pose a risk to the patient,
screening procedures have been proposed to select the proper sub-group of the
hypertensive population for these intensive diagnostic procedures. These consist of
intravenous urography, radioisotope renography, peripheral plasma renin activity,
and Saralasin infusion.
In 1977, a task force from the National Heart, Lung and Blood Institute of the
National Institutes of Health recommended no radiologic or physiologic screening
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for renovascular hypertension for most patients [46]. Further supporting this
approach, MacNeil concluded that from anepidemiological viewpoint that only men
who are under 54 and not compliant with therapy should be further investigated for
renovascular hypertension [47]. Her projections assumed that ten percent of the
hypertensive population had renovascular disease, surely an overestimate. Reevalua-
tion of her data using a smaller estimate ofthe prevalence of renovascular hyperten-
sion may suggest that no hypertensive patients should be screened for renovascular
disease, if the cost-effectiveness of such effort is a major goal.
The risks involved in surgery are significant, and the improved results with newer
antihypertensive drugs frequently permit clinically adequate control of blood pres-
sure with few side effects. However, the problems of achieving lifelong compliance
with medications, and the possibility of progression of arterial stenoses and loss of
ability to control the blood pressure remain. The potential long-term effects of
antihypertensive therapy are unknown, and may not be as benign as anticipated.
Thus the benefits of detection and cure of renovascular hypertension should not be
forgotten.
One guideline for patient selection is clear: the patient must be an acceptable
surgical risk. Patients with recent myocardial infarction, congestive heart failure, or
angina, and patients who have already suffered debilitating cerebrovascular accidents
are unacceptable high risks [48]. They need not undergo diagnostic evaluation but
should be treated medically. Patients whose hypertension cannot be controlled
pharmacologically should be examined for surgically curable disease. Failure to
adhere to a pharmacologic regimen puts the patient at risk of significant end organ
damage and justifies screening for surgically correctable disease.
Several population groups have a high enough incidence ofrenovascular hyperten-
sion to justify screening. In white women between the ages of 20 and 40, in middle-
aged men with recent onset of hypertension, and in all hypertensive children,
screening for renovascular hypertension is worthwhile. Patients with an abdominal
bruit, especially a diastolic[49] or asystolic-diastolic bruit, should be screened ifthey
are surgical candidates. If the hypertension is difficult to control medically, or if the
patient is non-compliant to an effective regimen, intensive screening should be
undertaken. The risk of missing a curable lesion and subjecting the patient to
uncontrolled hypertension outweighs the expense and the risk of a thorough
diagnostic evaluation.
SCREENING PROCEDURES
The ideal screening test for any disease is a simple, safe, inexpensive examination
that identifies a sub-group of patients at high risk, so that only that sub-group need
besubjected to moredefinitive but moredangerous diagnostic procedures. In a useful
screening test, a moderate percentage of false-positive examinations is acceptable,
but significant false-negative results are unacceptable. The problem of screening for
renovascular hypertension is particularly complex since no currently available test is
without flaws.
Peripheral plasma renin activity (PRA). Since renal vascular hypertension pre-
sumably results from renin hypersecretion, demonstrating elevated circulating levels
of renin should help to identify those patients whose hypertension can be improved
or cured by a surgical revascularization procedure. Plasma renin activity, however,
varies not only with physiological parameters such as blood volume and sodium load,
but also with age, race, sex, and concurrent diseases such as diabetes mellitus
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whites and in women than in men. No carefully controlled investigation has yet
established "normal" levels for each of these groups.
Sealey et al. have attempted to correct for variations in plasma volume in
measuring PRA. They assume that twenty-four hours sodium excretion [53] on the
day prior to PRA assay accurately estimates volume status. Hypertensive patients
were divided into low, normal, and high renin groups by comparison with PRA and
sodium excretion levels from a group of normal, non-hypertensive patients. This
study and others established that 15 to 20 percent of hypertensive patients have
elevated PRA; 33 percent have low or suppressed PRA; and about 55 percent have
renin levels similar to those in the control population with similar sodium excretion
[54]. In these studies, renovascular hypertension was found most commonly in
patients with elevated PRA, often in patients with normal PRA, and rarely in
patients with low PRA.
Since PRA varies with age, race, and sex, PRA in hypertensive patients should
probably be matched with controls based on these variables as well as plasma
volume. PRA should be measured after furosemide administration and after several
hours of upright posture. The results should be reproducibly analyzed in alaboratory
with broad experience and carefully established normal values. Because of the
complex patient preparation, the numerous variables, and the wide range of PRA
level in renal vascular hypertension, PRA assay byitselfis probably not sufficientfor
identifying patients with renovascular hypertension [55].
Saralasin. A promising new approach to screening for renovascular hypertension
involves the use of specific angiotensin blockingagents, such as Saralasin. In a recent
investigation, three hundred hypertensive patients were given intravenous Saralasin
infusion [56]. Those whose blood pressure decreased by 10/8 mm Hg or more were
selected for urography and arteriography. Renin-dependent hypertension was veri-
fied surgically in fourteen of the thirty-one patients with a positive Saralasin test.
Results were even better in a similar investigation using Saralasin injected as a bolus
rather than by infusion [57]. The false-positive rate was only 9.5 percent. Several
false-negative Saralasin tests have subsequently been reported [58]. These patients
became normotensive following renal artery revascularization, although Saralasin
tests had been negative.
Thus far the best results have been obtained when Saralasin was administered in
the volume depleted state. While safer and less complicated than most other
screening procedures, Saralasin injection has occasionally resulted in severehypoten-
sive or severe hypertensive reactions [59].
If further studies confirm these results and refine the testing procedure, Saralasin
or a similar agent such as converting enzyme inhibitor may become the primary
screening test for identification of renin-dependent hypertensive patients. Thosewho
respond can then be selected for arteriography and renal vein renin assay.
Radionuclide studies currently used inthe evaluation ofrenovascular hypertension
assess renal function, arterial perfusion, and morphology of the kidney.
Orthoiodohippurate (OIH) is the most commonly used radionuclide to study renal
function (renogram). Most of this tracer is extracted on its first pass through the
kidney. Following intravenous injection of OIH, serial scintiphotographs of the
kidneys are obtained at rapid intervals for the first twenty minutes. Delayed
scintiphotographs are obtained one and two hours after injection.
The data are stored on videotape for later retrieval and generation of renal area
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curves. Although interpretation of these curves remains controversial, most investi-
gators believe that the initial slope represents mainly background radioactivity and
rapidly accumulating activity in the renal vasculature. The second portion of the
curve reflects activity accumulating in the tubules as well as background and renal
vascular activity. In the third portion, activity diminishes in the kidney as OIH passes
into the ureter.
In the presence of renal artery stenosis, OIH is extracted from the blood less
rapidly than usual, resulting in a decrease in the slope of thefirst and second portion
of the curve and a delay in peak activity. The slope ofthe third portion ofthe curve is
also reduced, most likely because transit of OIH through the tubules is prolonged,
due to greater absorption of water and sodium in the hypoperfused kidney. While
this pattern is typical of renovascular disease, it is not specific. Similar curves result
from dehydration, sodium depletion, renal disease, and obstruction of the renal
pelvis or ureter.
Farmelant and Burrows [60] prefer comparison of renogram curves of the two
kidneys to comparison with values derived from a selected normal population. In
screeningfor unilateral renovasculardisease, these and other authors[61] believe that
the descending portion is the most reliable segment ofthe curve. Farmelant and co-
workers considered a difference of 20 percent or more in the fifteen-minute relative
retention of radioactivity between the two kidneys (as measured from the time the
first kidney reached peak activity) as significant. Farmelant et al. [62] found a false-
negative rate of 7 percent (four offifty-eight patients) and a false-positive rate of 10
percent (four of forty-one patients) in a group of ninety-nine hypertensive patients.
Maxwell et al. [63] evaluated the accuracy of multiple renographic studies for
renovascular disease and found false-positive rates between 0 and 53 percent, and
false-negative rates ranging from 0 to 46 percent. Blaufox et al. [64] state that most
centers report false-positive andfalse-negative rates ofabout 30 percent similar to the
accuracy rate of the rapid sequence intravenous urogram.
Renal morphology is most often studied on scans obtained following 99m Tc-
DTPA or 99m Tc-DMSA [65] injection. Kidney size and shape are evaluated in
various projections. Since many conditions alter kidney size and shape, the scan is
non-specific. Since the kidneys may have normal size and shape in the presence of
renovascular hypertension, the scan lacks sensitivity.
Study of renal perfusion is most often performed with technetium pertechnetate
[66]; this is an excellent compound to evaluate renal blood flow, since only a fraction
is extracted by the kidney.
Following injection, scintiphotographic exposures are obtained every five seconds
for two minutes and recorded on videotape for generation of time activity curves.
These curves reflect separately the radioactivity in the abdominal aorta and in each
kidney. Differential renal blood flow in the two kidneys may be apparent on visual
inspection ofthe scintiphotos and the curves. For quantitative measurements, Adam
et al. [67] found the time to peak activity (T41) to be most sensitive, while Rosenthall
found the time to peak activity plus the time to one-half peak activity more reliable.
Koenigsberg et al. [68] evaluated the sensitivity of perfusion scanning in detecting
differential renal artery flow rates in dogs. Visual assessment was only reliable in
identifying differences in flow rates in the two renal arteries of 40 percent or more.
Quantitative analysis permitted detection of differential flow rate if the difference in
rate was 25 percent or more.
While this study promises to be useful in screening for renovascular disease, more
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Currently it is used as an adjunct to other tests.
The function study (renogram) is currently the most widely used radionuclide
study in screening for renovascular hypertension. It is associated with false-negative
and false-positive rates of 10 to 20 percent, a diagnostic accuracy comparable to the
rapid sequence IVP. Because of the high incidence of false-negative results, its
usefulness as a screening procedure has beenjustifiably questioned.
Intravenous urography is an excellent means ofdemonstrating diseases ofthe renal
parenchyma and collecting system. Focal or diffuse renal scarring, renal masses, and
obstruction of the renal pelvis or ureter are readily demonstrated. The presence of
any of these abnormalities may influence therapeutic decisions, whether or not
subsequent evaluation verifies a relationship to the patient's hypertension.
In addition, intravenous urography may be helpful in identifying patients with
renal ischemia due to renal artery stenosis. The three urographic abnormalities most
frequently associated with renovascular hypertension are(1) disparity in renal length,
(2) difference between the kidneys in the time of initial opacification ofthe collecting
structures, and (3) difference in the density of contrast medium in the collecting
structures of the two kidneys [69].
Renal length is best measured on the initial film, during the time of maximal
opacification of the renal parenchyma. Unilateral renal artery stenosis should be
suspected if the left kidney is more than two centimeters longer than the right, or if
the right kidney is more than 1.5 centimeters longer than the left, assuming the
kidneys are normal in shape and the caliceal anatomy is comparable.
Contrast medium injected intravenously is thoroughly mixed with blood during its
passage through the heart. Normally, contrast medium should reach the glomeruli on
both sides simultaneously. If the two kidneys function symmetrically, glomerular
filtration and passage through the renal tubules should be simultaneous. In the
presence of unilateral or asymmetrical renal artery stenosis, blood flow rate and the
rate of glomerular filtration of contrast medium in the affected kidney are reduced.
The most easily observed and measured urographic sign of reduced filtration rate is
delayed opacification of the renal calices. If the calices of one otherwise normally
functioning kidney become opacified one minute or more before the other, renal
artery stenosis should be suspected.
Although the rate of glomerular filtration is decreased in the presence of renal
artery stenosis, absorption of water from the renal tubules is increased. Increased
water reabsorption results in greater concentration of the contrast medium in the
urine produced by the affected kidney. The presence of a visible difference in
concentration of contrast medium in the collecting systems of the two kidneys
suggests unilateral renal artery stenosis.
In the Cooperative Study, at least two of these urographic studies were present in
45 percent ofthepatients withsignificant unilateral renal artery stenosis, whereas the
urograms of only 0.5 percent of patients without unilateral renal artery stenosis
demonstrated two or more of these abnormalities [69]. The most reliable single
urographic abnormality in this study was delayed caliceal appearance time.
In the presence of renal artery stenosis, collateral circulation frequently develops.
Collateral circulation via the ureteral artery results in dilatation and tortuosity ofthis
vessel, which accompanies the ureterthroughout its length. Occasionally, notching of
the ureter due to compression by a tortuous ureteral artery may be visible on the
urogram. Although venous tortuosity unrelated to renal artery stenosis may also
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produce ureteral notching, the presence of this abnormality in a hypertensive patient
supports the suspicion of renal artery stenosis.
Currently screening tests are not accurate enough to constitute an endpoint in a
patient's workup. The hypertensive IVP and radionuclide renogram are both
associated with false-positive and false-negative rates of ten to twenty percent. This
percentage is too high to rely on either of these tests to exclude renovascular
hypertension in patients considered to be surgical candidates. The efficacy of the
Saralasin infusion test as a routine screening procedure needs to be evaluated further.
However, we perform intravenous urography prior to arteriography, not as a
screening procedure for renovascular disease but to provide anatomic information
about the kidneys (inflammatory or atrophic disease, masses, malformations).
Radioisotope renography may provide similar information but less directly. Whether
urography is normal or abnormal, arteriography is performed in all patients in whom
diagnostic evaluation for renin-dependent hypertension isjustified by clinical criteria.
ARTERIOGRAPHY
Arteriographic evaluation of the hypertensive patient requires careful demonstra-
tion of the entire renal arterial tree, from the orifice of the main renal artery to the
most peripheral intrarenal branches. Aortography provides safe and accurate
evaluation of the number of renal arteries present, and permits visualization of the
extrarenal portions of each of the renal arteries without risk of obstructing or
dissecting a stenotic orifice with a selectively placed catheter.
Following aortography, selective catheterization and injection of each of the main
renal arteries is performed unless contraindicated by stenosis at the renal artery
orifice [29]. Selective arteriography is important in evaluating extension of arterial
disease into intrarenal artery branches in the presence of stenosis of the main renal
artery, and in evaluating parenchymal and intrarenal vascular lesions in the absence
of main renal artery stenosis. Selective arteriography of each renal artery is particu-
larly important if the aortogram is normal. If the main renal arteries do not contain
stenoses, an intrarenal source of renin hypersecretion must be carefully excluded.
Arteriography provides direct, definitive demonstration of anatomic lesions that
may be responsible for renovascular hypertension. In addition to identifying arterial
stenoses and providing data which permit estimation of the degree of stenosis,
arteriographic findings are often sufficiently specific for diagnosis of the underlying
disease.
EVALUATION FOR SURGICAL CURABILITY
As mentioned above, the demonstration of an arteriographic abnormality is not
sufficient evidence that the lesion is responsible forthe hypertension and that surgical
repair will be successful. Biochemical demonstration of renin dependence is consid-
ered necessary. Peripheral renin levels are not helpful and Saralasin has not been
adequately evaluated as yet. Most centers rely on bilateral renal vein renin (RVR)
assays to prove renin dependence and predict cure at surgery. In spite of wide
experience with this procedure, the conditions under which the tests should be
performed and the ratios most predictive are still controversial. (See below). Many
false-positive and false-negative studies continue to be reported. Marks and co-
workers reviewed twenty-one published series comprising 412 patients and added
their own series of 56 patients, using each author's criterion for a positive examina-
tion [70]. They reported successful surgical results in 93 percent of patients who had
647abnormal RVR ratios and technically successful operations. However, they also
reported a large group of patients in whom RVR studies were considered non-
lateralizing. Of these, 57 percent were cured by surgery, indicating a large false-
negative rate with RVR ratio estimations. A carefully controlled study on large
numbers of patients in whom renal vein samples are obtained under optimal
conditions is obviously needed. Until such a study is reported, the incidence offalse-
positive and false-negative results can be kept at a minimum by ensuring careful
preparation of the patients and meticulous catheterization and sampling techniques,
by obtaining several samples from each site to serve as internal controls [71], and by
judicious selection of sampling sites based on arteriographic results [55].
The difference between the renin levels from the normal and abnormal kidney is
greatest under conditions which stimulate renin secretion. Consequently, the follow-
ing preparatory procedures are recommended.
The patient should receive no more than one gram of sodium per day for at least
three days prior to the examination. Furosemide (40 mg) should be administered the
night before and again on the morning of the examination. These measures reduce
blood volume and stimulate renin. The patient should be recumbent for twelve hours
prior to the procedure in order to ensure a relatively steady level of renin secretion.
Those antihypertensive medications whose mechanism of action blocks renin release
should be stopped at least twenty-four hours before the renal vein samples are
collected.
For interpretation of RVR levels, a ratio is constructed comparing the level
measured from an abnormal site to the level from a normal site. Most investigators
consider a ratio of 1.5 to1 as the upper limit of normal [55,72,73]. Several reports
describe high false-positive rates using this ratio and conclude that ratios of 2 to 1 are
necessary to diagnose and localize renin-dependent hypertension [71,73]. However,
in these reports some samples were obtained without renin stimulation by low
sodium diet and diuretic administration.
In patients with stenosis of the extrarenal portion ofone or both renal arteries and
no arteriographic abnormality in the intrarenal arteries or renal parenchyma, a set of
venous samples for renin assay is drawn from the main renal vein of each kidney.
Since levels of renin secretion maychange from moment to moment, control samples
from a peripheral site are drawn with each set of renal venous samples. A sudden
increase in renin secretion due, for example, to anxiety is reflected in the peripheral
sample, avoiding misinterpretation of factitious renin levels measured in one or both
renal venous samples.
At least two and preferably three sets ofsamples from each of the renal veins and
from a peripheral site are drawn, to ensure that variance of the assay technique and
changes in renin secretion affecting any single sample can be identified and dis-
counted [74]. Drawing three sets of blood samples from several sites is technically
tedious and expensive, but shortcuts to reduce the number of samples should be
avoided. The clinical implications of the RVR levels are major and vagaries of the
laboratory assay and of renin secretion are numerous. Although the reported
accuracy rates of 85 to 90 percent are impressive, care must be taken to avoid
misinterpretation. Verification of the accuracy of renal vein renin results by pharma-
coangiography and by drawing a sufficient number of samples to provide internal
control are the best available means of documenting the validity of a decision to
attempt surgical revascularization or to avoid surgery in individual patients.
In the absence of stenosis of the main renal artery, renal venography for renin
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assay should be performed if: (1) stenosis or obstruction is visualized or suspected in
the intrarenal arteries on selective renal arteriography; (2) if renal parenchymal
abnormalities suggesting infarction, scar, cyst, or tumor are identified by selective
arteriography.
Venous samples drawn from the main renal vein often do not identify renin
hypersecretion due to localized abnormalities of the arterial tree or parenchyma.
Because of streaming within the renal vein or because of duplication of renal vein,
samples drawn from the main renal vein may lead to false-negative results. When
blood is drawn directly from the vein that drains the affected region, these anatomic
sampling errors are avoided [32,74,75].
Arteriography should precede venous sampling so that appropriate sampling sites
can be selected. Arterial injection of contrast medium alters renin secretion. There-
fore, venous sampling should not be performed on the same day as the arteriogram.
Arteriographic manipulations may also determine the hemodynamic significance
of renal artery stenosis. Since collateral circulation does not develop in the absence of
a pressure gradient, demonstration of collateral arteries verifies that a stenotic lesion
is hemodynamically significant, and a careful search for collaterals should be made in
all patients with renal artery stenosis. If they can be identified, the likelihood is high
that surgical revascularization will succeed, iftechnicallyfeasible. But demonstration
of collaterals is possible in only a minority of patients with renal vascular hyperten-
sion.
Bookstein and co-workers have proposed pharmacoangiographic techniques for
increasing the frequency of collateral demonstration and for documentating their
hemodynamic significance [76]. These techniques involve selective injections after
pharmacologic alteration of the pressure gradient across stenotic renal arteries.
Epinephrine induces constriction ofperipheral vessels and diminution or obliteration
of any pressure gradient that may exist across a stenosis. This results in reduced or
reversed flow through collaterals, often permitting opacification of collaterals on
selective arteriographic injections. Acetylcholine produces peripheral vasodilatation,
augmentation of a pressure gradient if one is present, and increased collateral flow,
but reduces the likelihood that collaterals will be opacified in a retrograde direction
during selective arteriography.
This method correctly predicted that renal artery stenoses were hemodynamically
significant in nine patients, with 100 percent subsequent confirmation [76]. In 11
other cases prediction that stenoses were not hemodynamically significant by
pharmacoangiography was also subsequently confirmed.
Although these results represent relatively few cases, they are highly promising.
Since the method is without reported complication, it deserves confirmation and
perhaps wide application, particularly in patients with bilateral renal artery stenosis
and in patients with abdominal aortic coarctation, in whom surgical decisions are
most difficult.
Other examinations have been suggested to determine surgical curability once a
lesion has been found, including split renal function tests, bilateral renal biopsies,
measurement of the pressure gradient across an arterial lesion at surgery, and
responsiveness to incremental infusions of angiotensin II. The most useful of these
are split renal function tests. Differential renal ischemia can be demonstrated and
surgical curabilitypredicted bycomparing urine volume and sodium concentration in
the urine of the two kidneys. According to Howard [77], the volume of urine flow
from an ischemic kidney should be at least 60 percent lower than the volume from a
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glomerular filtration rate, which is decreased in the presence of renal artery stenosis.
The concentration of sodium in the urine depends upon the fractional excretion of
sodium and the amount of water reabsorption in the tubules of the kidney. In the
presence of renal ischemia, fractional excretion of sodium and water is decreased.
Urine osmolality and creatinine concentration are increased. Investigation of volume
of urine production and sodium concentration by each kidney requires cystoscopy
and bilateral retrograde ureteral catheterization [78,79,80]. The procedure is difficult,
unpleasant, and potentially hazardous. Since assay of renal venous blood for renin
provides similar information with greater accuracy, and less morbidity, the role of
split renal function tests in evaluating patients with renovascular hypertension is
minimal.
SURGERY FOR RENOVASCULAR HYPERTENSION
From a successful but relatively unsophisticated beginning, surgical techniques for
renovascular hypertension have progressed concomitantly with improvements in
diagnostic measures [48]. With proper patient selection, using thorough diagnostic
evaluation, sustained improvement in the level of hypertension has been achieved in
more than 90 percent of patients following successful surgery [48]. The prime
objective or successful renovascular surgery is to preserve renal function while
rendering the patient normotensive and eliminating the need for antihypertensive
medication. In a number of patients, however, especially those with hypertension of
long standing, expectations following successful surgery may need to be tempered
with the realization that the patient may still require some smaller amount of
medication on a continuing basis.
In most instances, antihypertensive drugs should be continued until the time of
surgery, although diuretics should be kept to a minimum to avoid volume depletion.
Intravenous fluids are given prior to surgery to insure satisfactory hydration and a
urethral catheter is inserted before operation to monitor urinary output and to
prevent bladder distention from mannitol-induced diuresis during surgery.
A transperitoneal anterior abdominal incision is used. The renal vessels are usually
exposed by colonic reflection together with duodenal mobilization (Kocher's maneu-
ver). In right-sided lesions more extensive dissection and mobilization of the vena
cava and right renal vein are necessary to gain access to the origin of the right renal
artery.
Autogenous saphenous vein [81,82] or synthetic material, usually dacron [83,84]
have been the materials most frequently employed for a bypass graft, although
recently the use of autogenous internal iliac artery has been advocated [85].
Saphenous veins are readily available, easy to work with, and usually have a caliber
appropriate for an anastomosis to the renal artery. Autogenous veins are less
thrombogenic than prosthetic materials and the rate of postoperative occlusion has
been reduced to as low as 5 percent[86]. Progressive dilatation ofthe vein graft after
a period ofyears has been reported in a small number of cases, with some increasing
to aneurysmal proportions [87].
Autogenous internal iliac artery bypass is theoretically attractive since the likeli-
hood of subsequent anastomotic stenosis or dilatation is diminished. However,
although the internal iliac artery is readily available and may be sacrificed without
danger to pelvic organs, obtaining sufficient length may be difficult, and the artery
may itself be involved by artherosclerosis. If so, it may be possible to perform
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endarterectomy prior to placement of the graft, or to use a piece of external iliac
artery, restoring continuity of blood flow to the extremity with a dacron graft [86].
Many vascular surgeons have lost enthusiasm for dacron since a high frequency of
thrombosis has been reported with dacron grafts in peripheral arteries. However,
dacron grafts may be more effective in the renal artery, since only a short length is
needed and since blood flow rate is so much higher than in diseased arteries ofthe leg.
In the presence of a diseased arterial wall, synthetic grafts eliminate the risk of
subsequent narrowing of the graft by progression of arterial disease [88].
Severe atherosclerosis or previous surgical procedures occasionally preclude
grafting into the aorta. In these cases, the splenic artery[89] for left side lesions or the
hepatic artery [90] for right-sided lesions may be used. Hepatic artery bypass requires
the juxtaposition of a piece of saphenous vein between the main or right hepatic
artery and the right renal artery [90]. Splenic artery bypass of left-sided renal artery
stenosis was described as early as 1957 [89].
Endarterectomy of stenoses involving the proximal portion of the renal artery has
recently been advocated. Using a transaortic approach, renal artery revascularization
can be accomplished with a single maneuver requiring a relatively short period of
renal ischemia [85]. Since no autogenous or prosthetic grafts are used, late complica-
tions associated with grafts are avoided.
Endarterectomy can also be performed directly through a renal arteriotomy, a
technique which avoids cross-clamping the aorta. The renal arteriotomy is frequently
closed with a venous patch graft to prevent stenosis at the suture line. This technique
may prove difficult when significant disease extends into the aorta, or in elderly
patients in whom an extremely thin arterial wall may remain after removal of the
plaque.
Localized stenoses in the mid-portion of the renal artery may be resected and
closed by end-to-end anastomosis of the renal artery. This technique, which requires
careful preparation since the extent of disease may be greater than demonstrated by
arteriography, may be facilitated by mobilization of the entire kidney. A variation of
this,technique is segmental resection and renoaortic re-implantation, used if stenosis
is localized at the renal artery origin.
Ex-vivo arterial repair and autotransplantation was described in the early 1960s
[91,92]. Widespread application of renal allograft surgery has made generally
available the knowledge and experience necessary for renal autotransplantation, but
the indications for this procedure in the treatment of renovascular disease are quite
limited [93]. With this technique, meticulous microsurgical methods may be used to
repair stenoses in vessels too small for repair by more conventional procedures. A
prolonged period of renal ischemia is made possible by hypothermia, induced and
maintained either by pulsatile perfusion or by simple cold perfusion. Because of
hypothermia, the operative field is bloodless, laborious reconstruction can be
performed at an appropriate pace, and time is available to check the anatomic results
by ex-situ arteriography [94].
Arterial lesions in the upper or lower pole, which are too peripheral for adequate
repair, may be treated with partial nephrectomy. After ligation of the diseased
segmental artery, the area which it supplies become ischemic and the plane of
resection is obviously demarcated. Nephrectomy may be the only possible procedure
in the presence of diffused parenchymal disease, fibrous encapsulation of the kidney
[95], multiple branch stenoses, or following unsuccessful vascular reconstruction.
However, nephrectomy should only be considered as alast resort, since even atotally
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occluded renal artery with a completely non-functioning kidney is not necessarily
irreparable. Return of renal function following revascularization has been achieved
in such cases, provided that the glomerula remain viable, as determined by surgical
biopsy and frozen section [93].
The success rates following renovascular surgery depend on multiple factors
including the age of the patient, the duration of the hypertension, the presence of
bilateral disease, and the technical skill of the surgeon. However, with proper patient
selection, sustained improvement in the level of hypertension should be possible in
more than 90 percent of patients. Operative mortality rates for this type of surgery
range between 3 percent and 8 percent.
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